What Does Red Light Do to Your Brain?

Red and near-infrared light, when applied to the head, can boost energy production inside brain cells by activating a key enzyme in the mitochondria called cytochrome c oxidase. This process, known as photobiomodulation, triggers a cascade of downstream effects: increased blood flow, reduced inflammation, and the release of molecules that support neuronal survival and repair. The science is still maturing, and most of the strongest evidence comes from animal models and small human trials, but the breadth of brain-related changes documented so far is striking enough to have drawn serious research attention over the past two decades.

How Light Reaches Brain Cells and What Happens When It Does

The story starts at the mitochondria, the energy-producing structures inside every cell. Cytochrome c oxidase (CCO) sits within the mitochondrial electron transport chain and acts as the primary light absorber for red and near-infrared wavelengths (roughly 600 to 1100 nanometers). When photons hit CCO, they appear to knock loose nitric oxide molecules that have been sitting on the enzyme and slowing it down. With nitric oxide out of the way, electron transport picks back up, the mitochondrial membrane potential rises, and the cell produces more adenosine triphosphate, the molecule cells use as fuel.¹

That freed nitric oxide doesn’t just vanish. It drifts into the surrounding tissue and relaxes blood vessel walls, which is one reason red light tends to increase local blood flow. Under low-oxygen conditions, something slightly different happens: the enzyme itself can generate new nitric oxide rather than merely releasing pre-existing stores, which may explain why photobiomodulation sometimes shows stronger effects in injured or oxygen-starved tissue.²

The boost in cellular energy isn’t trivial. More ATP means neurons can maintain ion gradients, release neurotransmitters, and carry out repair processes that they otherwise might not have the metabolic budget for. This is why the research interest extends well beyond simple wound healing into neurological conditions where energy failure is part of the problem.

Getting Light Through the Skull

One of the biggest practical hurdles is that the human skull and scalp are not transparent. A review of penetration studies across multiple species found that only about 0.2 to 10 percent of red and near-infrared light (630 to 810 nm) makes it through human scalp and skull tissue to reach the brain.³ That’s a far cry from the 60 to 70 percent penetration seen in mouse skulls, and it’s the main reason you can’t simply scale up mouse results to humans by using the same power levels.

The wide range in that 0.2 to 10 percent figure reflects real differences in wavelength, device type, and where on the head the light is applied. Near-infrared wavelengths around 810 nm tend to penetrate better than shorter red wavelengths around 630 nm, because longer wavelengths scatter less in tissue. Thinner skull regions like the temples or forehead allow more light through than the thick parietal bone at the top of the head. Researchers working on transcranial photobiomodulation typically compensate by using higher-powered devices, longer treatment times, or both.

An alternative approach sidesteps the skull entirely. There is evidence that photobiomodulation applied to the body can trigger systemic effects that reach remote organs, including the brain. The mechanisms behind this “abscopal” response are not yet well understood, but the finding implies that targeting accessible tissue like the abdomen or limbs might still influence brain biology indirectly.⁴

Blood Flow and Oxygenation Changes

Even at the small fraction of light that gets through, measurable changes happen. In a study using broadband near-infrared spectroscopy to track brain hemodynamics during and after transcranial infrared laser stimulation, researchers found significant increases in oxygenated hemoglobin and total hemoglobin in the targeted cortex, along with an increase in oxidized CCO concentration. These changes persisted after the light was turned off, suggesting a sustained metabolic shift rather than just a momentary blip.⁵

In a clinical case series of veterans with chronic traumatic brain injury, pulsed red and near-infrared LED treatment increased regional cerebral blood flow in two-thirds of participants, confirmed by SPECT brain imaging.⁶ Blood flow matters in the brain because neurons are voracious consumers of oxygen and glucose. Any sustained improvement in delivery can support better function, especially in regions that have been compromised by injury or disease.

It’s worth noting that visible colored light also affects brain hemodynamics through a completely different pathway: the visual system. When colored light enters the eyes, the visual cortex responds with measurable blood flow changes. One study found that red, blue, and green light all increased oxygenated hemoglobin in the visual cortex, though only blue light produced significant changes in the prefrontal cortex.⁷ This visual-pathway effect is separate from the transcranial photobiomodulation mechanism, where light is applied directly through the skull to the brain tissue. The distinction matters if you’re evaluating products: a red LED panel you stare at and one you press against your forehead are doing different things.

Tamping Down Brain Inflammation

After a brain injury, immune cells called microglia rush to the damaged area. They can adopt different states: a pro-inflammatory one that helps clean up debris but can also harm healthy tissue, and an anti-inflammatory one that promotes repair. Red and near-infrared light appears to nudge microglia toward the repair-oriented state. In a study using 808 nm light, the shift between these states depended heavily on dose, with lower energy densities favoring the anti-inflammatory profile and higher ones pushing toward the pro-inflammatory side.⁸

A recent study in a mouse model of traumatic brain injury found that 1064 nm LED treatment pushed both microglia and astrocytes (another type of brain support cell) toward anti-inflammatory states. The treatment also strengthened the blood-brain barrier by increasing production of tight junction proteins, which are the molecular bolts that keep the barrier sealed.⁹ A leaky blood-brain barrier is a hallmark of brain injury and several neurodegenerative diseases, so anything that helps maintain its integrity has broad therapeutic relevance.

Growth Factors and New Connections

Beyond immediate energy and inflammation effects, red and near-infrared light can stimulate the production of brain-derived neurotrophic factor (BDNF), a protein that supports the survival of existing neurons and encourages the growth of new ones. In mice with traumatic brain injuries treated with low-level laser therapy, BDNF was significantly increased in the hippocampus and another neurogenic zone within the first week. By four weeks, a different marker, synapsin-1, which indicates the formation of new connections between neurons, was elevated in the injured cortex.¹⁰ The timeline is suggestive: BDNF rises first, and synapse formation follows weeks later, consistent with the idea that the growth factor sets the stage for structural rewiring.

Mouse studies using transcranial photobiomodulation have also shown improved memory and learning, increased populations of neuroprogenitor cells (the precursors to new neurons), and more synaptogenesis in the cortex.¹¹ In aged mice, near-infrared light protected synapses from depletion, increased neuronal survival, and boosted synapse-related protein expression.¹² These are animal results, but they point to a consistent pattern: photobiomodulation doesn’t just give cells a temporary energy boost, it can shift the brain toward a more growth-friendly state.

The Dose Problem

More light is not always better, and this is one of the most important things to understand about photobiomodulation. The field has a well-documented biphasic dose response, sometimes called the Arndt-Schulz curve: too little light does nothing, a moderate dose helps, and too much can actually inhibit healing. In a mouse traumatic brain injury model, three daily treatments at a specific near-infrared dose significantly improved neurological and cognitive function. But when the same parameters were delivered fourteen days in a row, the benefit was significantly reduced. Interestingly, once the excessive treatments stopped, brain repair resumed, suggesting the inhibition was temporary rather than destructive.¹³

The dose-dependence showed up in the inflammation data too: lower energy densities pushed microglia toward a healing state, while higher densities flipped them toward the inflammatory side.⁸ This means that someone blasting their forehead with the most powerful consumer device they can find for as long as possible isn’t just wasting their time, they may be actively undermining the effect they’re trying to achieve.

What the Human Clinical Trials Show So Far

The most studied brain application is traumatic brain injury. In an open-protocol study of patients with chronic mild TBI, LED treatments applied to the head over several weeks produced statistically significant improvements on tests of executive function and verbal learning and memory. Participants also reported better sleep, fewer PTSD symptoms, and improved ability to handle social and work functions.¹⁴ That study lacked a sham control, though, so it’s important to interpret the results cautiously. The researchers themselves called for placebo-controlled follow-ups.

In dementia, a small study using a near-infrared device found that active treatment produced an average increase of about 5 points on the Mini-Mental State Examination, along with improvements of roughly a quarter on trail-making tests and gains on naming and verbal learning tests. Many patients reported better sleep within a week, and caregivers noticed less anxiety, improved mood, and better daily routines within two to three weeks.¹⁵ A 5-point MMSE gain is substantial for dementia patients, where the typical trajectory is decline. But small sample sizes make it premature to draw firm conclusions.

Parkinson’s disease research is at a similar early stage. Pre-clinical animal studies consistently show that near-infrared light protects dopamine-producing neurons. In one experiment, near-infrared light delivered intracranially preserved more dopaminergic cells in the brain region most affected by Parkinson’s compared to untreated controls.¹⁶ A small number of clinical trials have reported improvements in both motor and non-motor symptoms, and some suggest the possibility of slowed progression, though the evidence base remains limited.¹⁷

Depression and anxiety have also been explored. In a pilot study of ten patients with major depression and anxiety, a single near-infrared treatment to the forehead led to remission-level scores on standard depression scales in six of ten patients and on anxiety scales in seven of ten, with the greatest reductions at two weeks post-treatment.¹⁸ Ten patients and no control group make this hypothesis-generating at best, but the magnitude and persistence of the response have fueled further investigation.

For stroke, animal data has been encouraging. In a rat model, near-infrared treatment for two hours after stroke reduced brain injury by about a fifth in the first day, and extended treatment achieved over 50 percent reduction in infarct volume measured at one and two weeks.¹⁹ Human stroke trials, however, have had mixed results, and no photobiomodulation treatment is currently approved for acute stroke care.

Effects in Healthy Brains

You don’t have to have a neurological condition to see effects. In a study of healthy young adults, a single session of 850 nm near-infrared light applied to the right prefrontal cortex significantly improved reaction times on an attention task and altered brain electrical activity measured by EEG.²⁰ The implication is that even normally functioning mitochondria can be pushed to work a bit harder, giving neurons a metabolic advantage during demanding tasks. Whether this translates to meaningful real-world cognitive enhancement, or whether the effect persists beyond the lab, remains an open question.

In Alzheimer’s disease mouse models, combined light stimulation reduced amyloid-beta plaques and improved spatial learning and memory in the Morris water maze test.²¹ A network meta-analysis comparing photobiomodulation with two other brain stimulation techniques for Alzheimer’s (transcranial direct current stimulation and repetitive transcranial magnetic stimulation) noted that photobiomodulation works through a distinct mechanism, directly targeting mitochondrial energy production rather than modulating electrical excitability, which may account for its particular cognitive effects.²²

Red Light Through the Eyes and Your Body Clock

There is a completely separate pathway by which red light affects the brain: through the eyes and the circadian system. This has nothing to do with photobiomodulation of brain tissue and everything to do with how light signals reach the brain’s master clock. Most people know that blue light at night suppresses melatonin and disrupts sleep, but the role of red light in circadian regulation is less well known.

Red light was long assumed to be circadian-neutral because it falls outside the peak sensitivity range of melanopsin, the light-detecting pigment in the retinal cells that drive melatonin suppression. But research has shown that red light can still reset the human circadian clock, likely by activating cone photoreceptors rather than melanopsin cells. In one study, exposure to red light in the morning shifted the melatonin rhythm about an hour earlier over three consecutive days.²³ This is why some sleep researchers recommend red-spectrum light for evening use: it’s less disruptive than blue or white light for melatonin production, but it’s not completely invisible to the circadian system. If used in the morning, it can help anchor your wake-up timing.

Practical Realities of Consumer Devices

The consumer market for red light panels and helmets aimed at the brain has exploded in recent years, but there are reasons to be cautious about how well these devices translate research results. Many lab studies use lasers, which produce coherent, focused beams that penetrate differently than the LEDs found in most consumer products. That said, comparative work suggests that LEDs and lasers with matching wavelengths and energy densities can produce similar biological effects, particularly when the LED array is placed in direct contact with the tissue.²⁴

Heat is a practical concern with any device worn against the head. LED arrays in contact with skin can generate enough warmth to cause discomfort or even mild burns if not properly managed with heat sinks or cooling fans. More critically, the biphasic dose response means that a device delivering too much energy per session could be less effective than a weaker one. Without standardized dosing guidelines for brain applications, consumers are essentially guessing at treatment parameters, which is not a great position to be in for a therapy where more can genuinely be worse.

The research community itself has acknowledged the challenge. Study protocols vary enormously in wavelength, power density, treatment duration, pulsing frequency, and number of sessions. This heterogeneity makes it difficult to compare studies head-to-head and helps explain why some trials report strong effects while others find nothing. Until standardized protocols emerge from larger controlled trials, treating the existing literature as pointing in a promising direction rather than confirming a proven treatment is the more honest reading.

How Photobiomodulation Compares to Other Brain Stimulation

Photobiomodulation occupies a unique niche among non-invasive brain stimulation methods. Transcranial magnetic stimulation and transcranial direct current stimulation, the two most established alternatives, work primarily by changing the electrical excitability of neurons. They can push neurons closer to or further from their firing threshold, and through repeated sessions, promote lasting changes in synaptic strength. Photobiomodulation takes a fundamentally different approach by targeting the cell’s energy supply rather than its electrical state.²²

This mechanistic difference has a practical upside: photobiomodulation devices are simpler, cheaper, and produce fewer side effects than magnetic or electrical stimulation. You don’t need a trained technician to operate an LED helmet the way you would for transcranial magnetic stimulation. The downside is that the evidence base for brain applications is much thinner, with fewer large randomized controlled trials and no FDA-cleared indications for neurological use as of now. The field sits at an interesting crossroads where the biological plausibility is strong, animal data is encouraging, and small human studies are suggestive, but the definitive trials that would move photobiomodulation from “promising” to “proven” for any specific brain condition are still underway.